26 related articles for article (PubMed ID: 35532291)
1. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
2. A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients.
Guo Y; Mao X; Qiao Z; Chen B; Jin F
Front Oncol; 2020; 10():579692. PubMed ID: 33194705
[TBL] [Abstract][Full Text] [Related]
3. Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity.
Zhang TA; Zhang Q; Zhang J; Zhao R; Shi R; Wei S; Liu S; Zhang Q; Wang H
BMC Med Genomics; 2023 Oct; 16(1):261. PubMed ID: 37880674
[TBL] [Abstract][Full Text] [Related]
4. Analysis of endometrial carcinoma TCGA reveals differences in DNA methylation in tumors from Black and White women.
Asif H; Foley G; Simon M; Roque D; Kim JJ
Gynecol Oncol; 2023 Mar; 170():1-10. PubMed ID: 36580834
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Signatures in Vaginal Fluid Samples for Detection of Cervical and Endometrial Cancer.
Doufekas K; Zheng SC; Ghazali S; Wong M; Mohamed Y; Jones A; Reisel D; Mould T; Olaitan A; Macdonald N; Teschendorff AE; Widschwendter M
Int J Gynecol Cancer; 2016 Jun; ():. PubMed ID: 27258725
[TBL] [Abstract][Full Text] [Related]
6. Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers.
Yu X; Yang Q; Wang D; Li Z; Chen N; Kong DX
PeerJ; 2021; 9():e10884. PubMed ID: 33628643
[TBL] [Abstract][Full Text] [Related]
7. Druggable genetic targets in endometrial cancer
Lehrer S; Rheinstein PH
Cancer Treat Res Commun; 2022; 30():100502. PubMed ID: 34933203
[TBL] [Abstract][Full Text] [Related]
8. Investigating skewness to understand gene expression heterogeneity in large patient cohorts.
Church BV; Williams HT; Mar JC
BMC Bioinformatics; 2019 Dec; 20(Suppl 24):668. PubMed ID: 31861976
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive DNA methylation-based testing for the diagnosis of endometrial cancer.
St Laurent J; Elias KM
Lancet Oncol; 2023 Dec; 24(12):1291-1292. PubMed ID: 37944539
[No Abstract] [Full Text] [Related]
10. Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation.
Ahn HM; Park I; Kim CG; Ko YK; Gim JA
J Environ Sci Health C Toxicol Carcinog; 2024 Feb; ():1-16. PubMed ID: 38409772
[TBL] [Abstract][Full Text] [Related]
11. Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression.
Jilani M; Degras D; Haspel N
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790260
[TBL] [Abstract][Full Text] [Related]
12. It is time to implement molecular classification in endometrial cancer.
Bruno V; Logoteta A; Chiofalo B; Mancini E; Betti M; Fabrizi L; Piccione E; Vizza E
Arch Gynecol Obstet; 2024 Mar; 309(3):745-753. PubMed ID: 37410149
[TBL] [Abstract][Full Text] [Related]
13. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
16. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
17. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
Wu Y; Wang J; Ge L; Hu Q
Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
[TBL] [Abstract][Full Text] [Related]
18. Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data.
Shen PC; Wang YF; Chang HC; Huang WY; Lo CH; Su YF; Yang JF; Lin CS; Dai YH
Jpn J Clin Oncol; 2022 Sep; 52(9):992-1000. PubMed ID: 35532291
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
